Bausch Health Companies (TSE:BHC) Trading Down 6.7% – Should You Sell?

Shares of Bausch Health Companies Inc. (TSE:BHC) dropped 6.7% on Friday . The stock traded as low as C$6.99 and last traded at C$6.99. 1,322,165 shares were traded during trading, an increase of 175% from the average session volume of 480,283 shares. The stock had previously closed at C$7.49.

Bausch Health Companies Stock Performance

The firm’s 50 day moving average is C$7.41 and its 200-day moving average is C$8.09. The stock has a market capitalization of C$2.57 billion, a price-to-earnings ratio of -2.12, a PEG ratio of 0.21 and a beta of 0.94. The company has a debt-to-equity ratio of -1,009.96, a quick ratio of 0.58 and a current ratio of 1.32.

Bausch Health Companies (TSE:BHC) last issued its quarterly earnings results on Wednesday, April 29th. The company reported C$1.08 earnings per share (EPS) for the quarter. Bausch Health Companies had a positive return on equity of 120.43% and a negative net margin of 13.54%.The company had revenue of C$3.51 billion for the quarter. Analysts forecast that Bausch Health Companies Inc. will post 5.5472637 earnings per share for the current fiscal year.

Bausch Health Companies Company Profile

Bausch Health Companies Inc is a global company that develops manufactures and markets a range of pharmaceutical medical device and over-the-counter products primarily in the therapeutic areas of eye health gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health. Our approximately 22000 employees are united around our mission of improving peoples lives with our health care products and we manufacture and market health care products directly or indirectly in approximately 100 countries.